Management of CRE Infections: High Time for an RCT?

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Clinical Research

Background:

• Carbapenem-resistant Enterobacteriaceae (CRE) pose a significant global health threat.
• Limited high-quality evidence exists for optimal management strategies of CRE infections.
• Current treatment approaches often rely on expert opinion and observational data.

Purpose of the Study:

• To highlight the urgent need for robust clinical evidence in managing CRE infections.
• To emphasize the critical role of randomized controlled trials (RCTs) in guiding clinical practice.
• To stimulate discussion and research into effective CRE treatment protocols.

Main Methods:

• This commentary reviews the current landscape of CRE infection management.
• It identifies gaps in evidence and advocates for specific research methodologies.
• The authors discuss the challenges and potential designs for future RCTs.

Main Results:

• There is a profound lack of high-level evidence from RCTs for CRE infection treatment.
• Existing treatment guidelines are often based on limited data, leading to suboptimal outcomes.
• The need for well-designed RCTs is paramount to improve patient survival and reduce antimicrobial resistance.

Conclusions:

• The current clinical approach to CRE infections is not adequately supported by evidence.
• Conducting RCTs for CRE infections is feasible and urgently required.
• Future research should focus on comparative effectiveness of different antibiotic regimens and adjunctive therapies.